The activating receptor NKp46 is essential for the development of type 1 diabetes. - Wikidata - awgldk - TriplyDB

The activating receptor NKp46 is essential for the development of type 1 diabetes.

The activating receptor NKp46 is essential for the development of type 1 diabetes.

http://www.wikidata.org/entity/Q43214288

about

Recognition and Regulation of T Cells by NK Cells The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetes Natural killer cell tolerance: control by self or self-control?TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes Elucidating the mechanisms of influenza virus recognition by Ncr1 NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization.Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses.Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins.Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease.NK cells are not required for spontaneous autoimmune diabetes in NOD mice.Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes.Type-specific human papillomavirus detection in cervical smears in Romania.Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor Circulating CD56+ cells of diabetic women show deviated homing potential for specific tissues during and following pregnancy.Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)Immunological Adaptations to Pregnancy in Women with Type 1 Diabetes NK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection.Nonviral-mediated hepatic expression of IGF-I increases Treg levels and suppresses autoimmune diabetes in mice.Diversity, function, and transcriptional regulation of gut innate lymphocytes Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells.Organ-specific features of natural killer cells The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity.Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.Receptors for non-MHC ligands contribute to uterine natural killer cell activation during pregnancy in mice Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetes Natural killer cells and their receptors in multiple sclerosis.Natural killer cells: multifaceted players with key roles in hepatitis C immunity.Natural killer cells in human autoimmune disorders Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression Innate immunity and the pathogenesis of type 1 diabetes.Natural killer cell education and tolerance.What causes type 1 diabetes? Lessons from animal models.Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands.Virus-mediated inhibition of natural cytotoxicity receptor recognition.

P2860

Q26742166-60E8FA44-1666-41F4-B178-8CA8D69C2677 Q27003384-8382FF41-6608-4F1D-9DF2-939710AAE33A Q27003931-E74B1857-59EC-42C8-8EE3-BFD00016167B Q27025559-9EB9042E-6549-4E98-A58D-F37533C77E1D Q28586365-76F20060-BB90-49C6-9270-EFFF9031A499 Q30665729-5F7B77E1-76B1-4D62-9F48-BE0CE6C9E71A Q33642649-76564C04-32AA-4206-8773-1942463D372A Q34030338-2F47F963-AABD-44F6-A8DE-9C2DD6587F73 Q34130220-5CC41266-7237-410C-9641-CDD427B1C274 Q34211527-FA4D5436-CF28-49C7-B8ED-E15C05BBCEF1 Q34257031-828220A1-4CC9-4C51-86CC-E30EB9618B52 Q34701422-0006056B-992D-43E2-8A86-4855F878A82E Q34802178-D886C485-5D16-4B24-99A9-6BFA2FF71E2D Q34979848-1165452D-CF24-4FE5-9937-D23C71504074 Q35094156-93D8166F-6D0E-4D7A-B3BB-9200D5B53376 Q35125149-D1CE32D9-62E5-4FF2-80F7-EA0D861A3B14 Q35142299-5107F367-79EC-4470-9ADE-81740FDAE8D0 Q35546855-55006350-165F-436E-8C55-AC313FC9932C Q35677989-2746ADF5-17D5-4B86-AACC-74EB55B07C00 Q35717216-88E0063B-5C80-4B31-89B5-07336F213D32 Q36099253-A3C29BD5-ACE9-4F52-81AA-6EA4C8F797A9 Q36175034-8F32907C-5F06-41FB-BDA8-D355FDD93EFC Q36560683-ED0D5126-1503-416C-AC08-22301B461A13 Q36693141-D010BE9E-37EC-4628-8C45-894473182DC3 Q36701917-721E7356-23F1-447A-B28A-EA3CC424ECD8 Q36750759-E634100D-789D-4518-9AD8-F80B86D33435 Q37022389-4BD9EAA1-3A44-4335-9AB4-761670139283 Q37088180-B276344B-7BC6-4D8F-B358-83BC32888828 Q37092549-D9F7BAB2-430D-4F39-A285-80A14C2E6158 Q37103886-14EA32E6-03A0-4C3E-A9AF-40E024728F9C Q37110531-07C89306-5810-4D36-B848-D836D7FDE009 Q37124504-821CA7DB-F4F5-4E14-9EBD-517E97691A37 Q37151472-1CA5895B-C488-470B-863A-97BA3F817A3A Q37690952-83D3B35F-4C6E-494D-A311-C2EA85705692 Q37727470-5B0B4C55-2F95-4805-817E-966862BD91F9 Q37728944-DAD71500-3B22-4E58-B2AF-4CFF7733A4E6 Q37789866-4207B541-6B41-4299-980E-595666ABDC27 Q37880270-31929C87-8216-4CBB-AE82-429DAEB31F57 Q38004630-C0EC9426-2143-4CE1-A1BD-848648CE4C4F Q38006620-DA7FAABF-8185-4081-A1E8-F9D09FED6A03

P2860

The activating receptor NKp46 is essential for the development of type 1 diabetes.

http://www.wikidata.org/entity/Q43214288

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

The activating receptor NKp46 is essential for the development of type 1 diabetes.

@en

The activating receptor NKp46 is essential for the development of type 1 diabetes.

@nl

type

label

The activating receptor NKp46 is essential for the development of type 1 diabetes.

@en

The activating receptor NKp46 is essential for the development of type 1 diabetes.

@nl

prefLabel

The activating receptor NKp46 is essential for the development of type 1 diabetes.

@en

The activating receptor NKp46 is essential for the development of type 1 diabetes.

@nl

P1433

Q43214288-4CE03CC6-A318-4991-829C-5B8FFABED152

P1476

Q43214288-52DB4BBB-523B-4480-9EFE-59BB20507460

P2093

Q43214288-1B436DC1-7828-4CD4-A3CA-D46767E438ED

Q43214288-32DDA5D8-3684-4309-AA37-EF9C5EB916B5

Q43214288-3881FAA6-221D-418D-A30B-AA014F99F7CC

Q43214288-475FE52A-83A8-413B-A824-D7F2356DC210

Q43214288-60498026-B3E4-444D-80EE-72A80D89B67D

Q43214288-7E64CF6B-2FE3-4614-9301-F62E84A17F6B

Q43214288-90A7DF2F-DD0B-4D96-9016-2A40D5E4062F

Q43214288-A6577D4F-1355-4F3E-B933-96B5761A4C8E

Q43214288-AEDEB58B-4A86-4D35-B10E-BD8E6353D229

Q43214288-B296458E-F2E8-400D-96CA-F69B2F88EA5C

P2860

Q43214288-12403CC1-E0F4-4E41-9ADD-1C7CD4B96CBF

Q43214288-28F27304-5BDA-4A19-AD16-B3D409A1DFFD

Q43214288-2EA85238-C90C-484C-8DA7-B68A30DA459B

Q43214288-2F2BA083-A480-4EBD-9F3D-4171D54BAB75

Q43214288-32ED3EAD-900D-4E7D-B9B3-F6A4D1F42CC2

Q43214288-40A96E03-6FBA-4C3F-B245-C8C4359677E8

Q43214288-4C9610A8-6323-4E1D-8B54-5A6CF2661B4D

Q43214288-518F6A65-C418-4F79-9FEA-0B4F8BB30D68

Q43214288-547572F3-4DC5-4B0B-A660-14CC24328981

Q43214288-5F08FCB4-CB03-41DB-AF8C-AA327DDBEC3E

P304

Q43214288-7026FCE0-C570-4C55-BB49-7C07D72E1EEE

P31

Q43214288-76D00D84-9216-42C4-9382-B1462518CBA8

P356

Q43214288-670A4314-87FB-4950-A46B-4D296789CC96

P407

Q43214288-2A676C9B-15CC-45DB-855E-F6A30281B776

P433

Q43214288-00E571AD-638C-4C7A-9DDC-EA2F18F72767

P478

Q43214288-4B547C12-40FC-4AF6-B8DB-3CED3B8050A5

P50

Q43214288-A06A3F11-131E-4EB2-8789-02F83187FBF5

Q43214288-CF42A651-2633-4FBE-A38A-08E6CFBD83F3

Q43214288-EB15AC7D-9F66-4752-9D11-B05053C3C1C3

P577

Q43214288-683D8E03-0641-47BE-B16E-38F2807C8AC5

P5875

Q43214288-D44E1D30-F971-400F-A2CD-0917A9434D80

P698

Q43214288-18B289BD-405E-4A1E-BE9A-1A046C82AF98

P921

Q43214288-D1769C9B-6A6B-4FBD-9E57-FDC858BCF3A8

P356

P1433

Nature Immunology

P1476

The activating receptor NKp46 is essential for the development of type 1 diabetes

@en

P2093

Chamutal Gur

http://www.w3.org/2001/XMLSchema#string

Hagit Achdout

http://www.w3.org/2001/XMLSchema#string

Hormas Ghadially

http://www.w3.org/2001/XMLSchema#string

Michal Mendelson

http://www.w3.org/2001/XMLSchema#string

Moran Elboim

http://www.w3.org/2001/XMLSchema#string

Ofer Mandelboim

http://www.w3.org/2001/XMLSchema#string

Oren Hershkovitz

http://www.w3.org/2001/XMLSchema#string

Saar Mizrahi

http://www.w3.org/2001/XMLSchema#string

Tomer Nir

http://www.w3.org/2001/XMLSchema#string

Victoria Doviner

http://www.w3.org/2001/XMLSchema#string

P2860

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.

Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity.

The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

What is a natural killer cell?

Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells

NK cells, MHC class I molecules and the missing self.

The natural killer cell -- friend or foe in autoimmune disease?

Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.

NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules

P304

121-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NI.1834

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Noam Stern-Ginossar

P577

2009-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40731151

http://www.w3.org/2001/XMLSchema#string

P698

20023661

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes